LONDON (MarketWatch) -- U.K. biotech Xenova has recommended an offer from Celtic Pharma, a private equity fund, which values the company at between 19.4 million pounds and 26.1 million pounds, a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results